TEVA PHARMACEUTICAL INDUSTRIES LIMITED Finance Lease, Right-of-Use Asset, after Accumulated Amortization
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $37.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-03
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $37.00M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $18.00M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $23.00M; Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed $32.00M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $29.00M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed |
|---|---|---|
| 2025-12-31 | $37.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $18.00M 10-K · filed 2026-02-03 | |
| 2023-12-31 | $23.00M 10-K · filed 2025-02-05 | $32.00M 10-K · filed 2024-02-12 |
| 2022-12-31 | $29.00M 10-K · filed 2024-02-12 | |
| 2021-12-31 | $32.00M 10-K · filed 2023-02-10 | |
| 2020-12-31 | $29.00M 10-K · filed 2022-02-09 | |
| 2019-12-31 | $37.00M 10-K · filed 2020-02-21 | |
| 2019-09-30 | $77.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $78.00M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $76.00M 10-Q · filed 2019-05-02 |